微信关注
China
Total item
Cart Subtotal
￥ 0.00 “abt”的搜索结果
39 个项目
每页
-
Paritaprevir (ABT-450)
Catalog No. A17625 HCV NS3/4A inhibitorParitaprevir (ABT-450) is a potent non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. 了解更多 -
Linifanib (ABT-869)
Catalog No. A10025 VEGFR/PDGFR 抑制剂Linifanib (ABT-869)是一种结构新颖的有效RTK，VEGF和PDGF抑制剂，对人内皮细胞，PDGFR-β，KDR和CSF-1R的IC50分别为0.2、2、4和7 nM。 了解更多 -
ABT-702 dihydrochloride
Catalog No. A19624 AK inhibitorABT-702 dihydrochloride is a potent adenosine kinase (AK) inhibitor (IC50=1.7 nM). 了解更多 -
Ombitasvir (ABT-267)
Catalog No. A17624 HCV NS5A inhibitorOmbitasvir is a potent inhibitor of the hepatitis C virus protein NS5A, with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype 6a. 了解更多 -
Upadacitinib (ABT-494)
Catalog No. A18316 JAK-1 抑制剂Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. IC50 & Target: IC50: 43 nM (JAK1), 200 nM (JAK2) 了解更多 -
ABT-199 (Venetoclax)
Catalog No. A12500 Bcl-2 抑制剂ABT-199 (Venetoclax) 是一种所谓的BH3类似药物，旨在阻断Bcl 2蛋白的功能。 了解更多 -
ABT-751 (E-7010)
Catalog No. A10024 Microtubule Associated 抑制剂ABT-751 (E-7010)是一种抗有丝分裂剂，可抑制微管聚合，并在秋水仙碱位点与β-微管蛋白结合。在G2M期阻断细胞周期并诱导凋亡。 了解更多 -
ABT-263 (Navitoclax)
Catalog No. A10022 Bcl-2 抑制剂ABT-263 (Navitoclax)是一种有效的Bcl-2家族抑制剂 (Bcl-2，Bcl-xL和Bcl-w的Ki <1 nmol/L)。ABT-263对Bcl- xL，Bcl-2和Bcl-w，( Ki≤1nmol/ L) 维持高亲和力，但与Mcl-1和A1的结合更弱。 了解更多 -
ABT-639 hydrochloride
Catalog No. A12571 T-type Ca2+ channel blockerABT-639 hydrochloride is a novel, peripherally acting, selective T-type Ca2+ channel blocker. 了解更多 -
ABT-046
Catalog No. A14984 -
ABT 492 meglumine (Delafloxacin meglumine)
Catalog No. A15064 ABT 492 meglumine (Delafloxacin meglumine)对喹诺酮敏感和耐药的革兰氏阳性生物更有力，对环丙沙星家族肠杆菌科的某些成员具有类似于环丙沙星的活性，对喹诺酮敏感，非发酵性，革兰氏阴性生物具有类似的活性。 了解更多 -
ABT-492 (Delafloxacin)
Catalog No. A10023 Fluoroquinolone antibioticABT-492 (Delafloxacin)是一种新的氟喹诺酮类药物，可抵抗155种需氧和171种厌氧菌。 了解更多 -
Atreleuton
Catalog No. A18623 5-Lipoxygenase (5-LO) inhibitorAtreleuton (ABT-761) is a selective, reversible, and orally bioavailable 5-Lipoxygenase (5-LO) inhibitor. Atreleuton (ABT-761) exhibits potent and selective inhibition of leukotriene formation. 了解更多 -
Sofinicline (ABT-894, A-422894)
Catalog No. A13842 -
Lopinavir (ABT-378)
Catalog No. A10537 -
Pibrentasvir
Catalog No. A22474 Pibrentasvir, also known as ABT-530, is a protease inhibitor potentially for the treatment of HCV infection. 了解更多 -
Alicapistat
Catalog No. A19490 alpains 1 and 2 inhibitorAlicapistat (ABT-957) is an orally active selective inhibitor of human calpains 1 and 2 for the potential use in the treatment of Alzheimer's disease (AD). 了解更多 -
Ilorasertib
Catalog No. A20982 ATP-competitive multitargeted kinase inhibitorIlorasertib (ABT-348) is a potent and ATP-competitive multitargeted kinase inhibitor, which inhibits Aurora C, Aurora B, and Aurora A with IC50s of 1 nM, 7 nM, 120 nM, respectively. 了解更多 -
Choline Fenofibrate
Catalog No. A15044 -
Pozanicline
Catalog No. A21318 Pozanicline (ABT-089) selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a novel cholinergic agent that is a partial agonist at α4β2* nAChRs (Ki=16 nM) and shows high selectivity for α6β2* and α4α5β2 nAChR subtypes, the binding affinity (Ki, rat) for Pozanicline to [3H] cytisine sites is 16.7 nM. 了解更多 -
Tebanicline hydrochloride
Catalog No. A21918 nAChR modulatorTebanicline hydrochloride (ABT594 hydrochloride) is a nAChR modulator with potent, orally effective analgesic activity. 了解更多 -
Seratrodast
Catalog No. A18134 thromboxane A2 (TXA2) receptor (TP receptor) antagonistSeratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. 了解更多 -
Glecaprevir
Catalog No. A16948 HCV NS3/4A protease 抑制剂Glecaprevir，也称为ABT-493和A-1282576，是一种新型的HCV NS3/4A蛋白酶抑制剂，IC50值在3.5至11.3 nM之间。 了解更多 -
Atrasentan HCl
Catalog No. A15007 Endothelin 拮抗剂 receptorAtrasentan hydrochloride是一种开发用于治疗前列腺癌的内皮素拮抗剂受体（IC50 = 0.0551 nM，ETA）。 了解更多 -
Atrasentan
Catalog No. A13779 ETA 拮抗剂Atrasentan是一种实验药物，正在研究中，用于治疗各种类型的癌症，包括非小细胞肺癌。它是对A型亚型（ETA）有选择性的内皮素受体拮抗剂,对ETA的IC50为0.0551 nM。 了解更多 -
Veliparib dihydrochloride
Catalog No. A21356 PARP inhibitorVeliparib dihydrochloride is a potent PARP inhibitor, inhibiting PARP1 and PARP2 with Kis of 5.2 and 2.9 nM, respectively. 了解更多 -
Nelonicline
Catalog No. A21079 neuronal nicotinic receptor agonistNelonicline (ABT-126) is a selective neuronal nicotinic receptor agonist. 了解更多 -
Zotarolimus
Catalog No. A11950 mTOR 抑制剂Zotarolimus是一种免疫抑制剂，可以抑制FKBP-12结合的IC50为2.8nM。。它是雷帕霉素的半合成衍生物。它设计用于以磷酸胆碱为载体的支架。 了解更多
39 个项目
每页
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
FILTER BY:
购物选项
- 分类
-
- Epigenetics (3)
- Apoptosis (3)
- PI3K / Akt / mTOR (1)
- Protein Tyrosine Kinases (1)
- Angiogenesis (1)
- JAK / Stat (1)
- DNA Damage (4)
- Cytoskeleton (1)
- Cell Metabolism (4)
- GPCR / G Protein (2)
- Neuronal Signaling (3)
- Proteases (4)
- Microbiology (4)
- Membrane Transporters/Ion Channels (2)
- Ready to Use Solution (7)
- Products On Sale (11)
- COVID-19 Related Products (1)
- 作用机制
-
- Inhibitor (抑制剂) (19)
- Agonist (激动剂) (3)
- Antagonist (拮抗剂) (4)
- Modulator (调节剂) (1)
- Blocker (阻断剂) (2)
- 靶点
ADOOQ 产品质量保证
We promise all products to perform as described.